Coura 1997.
| Methods | Non‐randomised study | |
| Participants | Adults | |
| Interventions | BZD (n = 26) 5 mg/kg/day (4 weeks) NFTMX (n = 27) 5 mg/kg/day (4 weeks) Placebo (n = 24) |
|
| Outcomes | Serological status recorded Xenodiagnosis recorded |
|
| Notes | Brazil 1997 | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | |
| Allocation concealment (selection bias) | Low risk | |
| Blinding of participants and personnel (performance bias) All outcomes | Low risk | |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Unclear |
| Incomplete outcome data (attrition bias) All outcomes | High risk | |